Genetic variation with MASLD reveals subtypes and potential therapeutic avenues

An astounding 30% of Americans currently have metabolic dysfunction-associated steatotic liver disease, or MASLD, which is formerly known as nonalcoholic fatty liver disease, or NAFLD, and many are unaware that they have it.